Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Advanced Enzyme Technologies Limited Regulatory Filings 2021

Nov 10, 2021

62369_rns_2021-11-10_63eda17e-0618-4a54-9834-8ec2ea5c753a.pdf

Regulatory Filings

Open in viewer

Opens in your device viewer

November 10, 2021

BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Exchange Plaza, Plot No. C/1, G Block Mumbai-400 001 Bandra-Kurla Complex, Bandra (E) Scrip ID-540025 Mumbai-400 051 Scrip Code-ADVENZYMES

Dear Sir/Madam,

Sub: Intimation of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015

We wish to inform you that pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst / Investor Meetings with the Company is as under:

ompany is as under:
Date Interaction With Type
November 17, 2021 Royce Investment Partners, USA Virtual, One-on-One
November 23, 2021 Dalton Investments in USA One-on-One

Note: The aforesaid is subject to change. Changes may happen due to exigencies on the part of Fund/Company.

The aforesaid information is also being uploaded on the Company’s website.

You are requested to kindly take a note of the same.

Thanking you, Yours faithfully, For Advanced Enzyme Technologies Limited

SANJAY Digitally signed by SANJAY PRAKASH PRAKASH BASANTANI BASANTANI Date: 2021.11.10 16:05:54 +05'30'


Sanjay Basantani Company Secretary and Head – Legal